Skip to main content
Log in

Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Therapeutic effect and the mechanism of the action of human urinary trypsin inhibitor (MTI) on experimental acute pancreatitis were studied. MTI significantly increased survival rate of animals with experimental acute pancreatitis induced by the infusion of trypsin or phospholipase A2 into pancreas or by a closed duodenal loop. The efficacy of MTI on these types of pancreatitis were higher than those of aprotinin. Pancreatic enzymes were released from pancreatic slice by trypsin or phospholipase A2, and this release was inhibited by MTI. Further, these pancreatic enzymes caused a secondary release of enzymes from other pancreatic slice, suggesting that these enzymes injured pancreatic tissue and that a chain reaction of pancreatic enzyme activation may play an important role in the pathogenesis of acute pancreatitis. MTI suppressed the secondary enzyme-induced pancreatic injury more strongly than aprotinin. These results suggest that MTI may suppress pathogenesis and development of pancreatitis by inhibiting the chain reaction of pancreatic enzyme activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Regan PT: Medical treatment of acute pancreatitis. Mayo Clin Proc 54:432–434, 1979

    Google Scholar 

  2. Elmslie R, White TT, Magee DF: The significance of reflux of trypsin and bile in the pathogenesis of human pancreatitis. Br J Surg 53:809–815, 1966

    Google Scholar 

  3. Ohnishi H, Kosuzume H, Ashida H, Kato K, Suzuki Y, Honjo I: Therapeutic effects of human urinary trypsin inhibitor on acute experimental pancreatitis. Nippon Yakurigaku Zasshi 81:235–244, 1983

    Google Scholar 

  4. Muramatsu M, Mori S, Matsuzawa Y, Horiguchi Y, Tanaka M: Purification and characterization of urinary trypsin inhibitor UTI68, from normal human urine and its cleavage by human uropepsin. J Biochem (Tokyo) 88:1317–1329, 1980

    Google Scholar 

  5. Prokch GJ, Routh JI: The purification of the trypsin inhibitor from human pregnancy urine. J Lab Clin Med 79:491–499, 1972

    Google Scholar 

  6. Kassell B: Bovine trypsin-kallikrein inhibitor. Methods Enzymol 19:844–852, 1970

    Google Scholar 

  7. Bruhn HD, Muller L, Duckert F: Quantitative determination of plasminogen. A caseinolytic method. Thrombos Diathes Haemorrh 23:191–201, 1970

    Google Scholar 

  8. Bieth J, Spiess B, Wermuth CG: The synthesis and analytical use of a highly sensitive and convenient substrate of elastase. Biochem Med 11:350–357, 1974

    Google Scholar 

  9. Shaw E: Site-specific reagents for chymotrypsin, trypsin and other serine proteases. Methods Enzymol 25:655–660, 1972

    Google Scholar 

  10. Petra PH: Bovine procarboxypeptidase and carboxypeptidase A. Methods Enzymol 19:460–503, 1970

    Google Scholar 

  11. Swanson AA, Martin BJ, Spicer SS: Human placental cathepsin B1. Biochem J 137:223–228, 1974

    Google Scholar 

  12. Starkey PM, Barret AJ: Human cathepsin G. Biochem J 155:273–278, 1974

    Google Scholar 

  13. Anonymous: Crystallized trypsin.In United States Pharmacopeia, 20th Rev. Rockville, The United States Pharmacopeial Convention, 1979, pp 834–835.

  14. Elliott DW, Williams RD, Zollinger RM: Alterations in the pancreatic resistance to bile in the pathogenesis of acute pancreatitis. Ann Surg 146:669–682, 1957

    Google Scholar 

  15. Lankisch PG, Winkler K, Bokermann M, Schmidt H, Creutzfeldt W: The influence of glucagon on acute experimental pancreatitis in the rat. Scand J Gastroenterol 9:725–729, 1974

    Google Scholar 

  16. Ferrie MM, O'Hare R, Joffe SN: Acute and chronic pancreatitis in the rat caused by a closed duodenal loop. Digestion 18:280–285, 1978

    Google Scholar 

  17. De Haas GH, Postema NM, Nieuwenhuizen W, Van Deenen LLM: Purification and properties of phospholipase A from porcine pancreas. Biochim Biophys Acta 159:103–117, 1968

    Google Scholar 

  18. Schmidt T, Creutzfeldt W: The possible role of phospholipase A in the pathogenesis of acute pancreatitis. Scand J Gastroenterol 4:39–48, 1968

    Google Scholar 

  19. Geokas MC, Murphy DR, McKenna RD: The role of elastase in acute pancreatitis. Arch Pathol 86:117–126, 1968

    Google Scholar 

  20. Toki N, Takasugi S, Sumi H: Isolation and characterization of a pancreatic elastase from plasma of patients with acute pancreatitis. Clin Sci 62:321–328, 1982

    Google Scholar 

  21. Inagaki Y, Tanaka Y, Takamura T, Sakakibara K, Nukuta N, Okuda N, Kano H: CPK elevation in pancreatitis. Nippon Shokakibyo Gakkai Zasshi 176:1993–2003, 1979

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohnishi, H., Kosuzume, H., Ashida, Y. et al. Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis. Digest Dis Sci 29, 26–32 (1984). https://doi.org/10.1007/BF01296858

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01296858

Keywords

Navigation